Evidence mapPaperPMID 41560754Full record

ReviewFrontiers in pharmacology2025

Dietary polyphenols maintain human health through modulation of gut microbiota.

Mithun Rudrapal, André M de Oliveira, Ravi Pratap Singh

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mithun RudrapalDepartment of Pharmaceutical Sciences, School of Biotechnology and Pharmaceutical Sciences, Vignan's Foundation for Science, Technology and Research, Guntur, India.
André M de OliveiraDepartment of Environment Studies, Federal Centre of Technological Education of Minas Gerais (CEFET-MG), Contagem, Minas Gerais, Brazil.
Ravi Pratap SinghDepartment of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Ranchi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The symbiotic interplay between dietary polyphenols and gut microbiota constitutes a focal point in contemporary scientific investigations, with profound impact in human health and diseases. The human gastrointestinal milieu serves as the locus for a diverse consortium of microbial organisms, collectively constituting the gut microbiota, which intricately modulate host metabolism, immune responses, and overall homeostasis. Dysregulation of gut microbial composition and functionality, known as dysbiosis, has been implicated in the progression of a plethora of gastrointestinal and systemic maladies, encompassing inflammatory bowel diseases, metabolic syndromes and neurological disorders, and so on. Polyphenols abundant in plant-derived food, exert multifaceted biological activities, encompassing antioxidative, anti-inflammatory and anticancer properties, among many others. These polyphenolic metabolites inextricably interact with the gut microbiota, exerting modulatory effects on microbial composition and functionality, thereby promoting the symbiotic physiological relationships between microbe and human host. In reciprocal fashion, the gut microbiota serves as pivotal vectors in the metabolism and bioavailability of polyphenols, engendering bioactive signalling metabolites which regulate systemic physiological effects and thereby maintain host health. This review emphasizes the imperative of comprehensively delineating an interplay between polyphenolic metabolites and gut microbiota in maintaining host health, while reflecting potential interventions of protective health outcomes in disease conditions.

Indexed as

dietary polyphenolsgut microbiotahealth outcomespolyphenol bioavailabilitypolyphenolmetabolites

Identifiers

PMID41560754
PMCPMC12813020

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.